{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:01:09Z","timestamp":1760043669011},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Hist"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10735-016-9685-0","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T05:24:58Z","timestamp":1466486698000},"page":"429-435","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry"],"prefix":"10.1007","volume":"47","author":[{"given":"Sooraj","family":"Baijnath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeola","family":"Shobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A.","family":"Bester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanil D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per I.","family":"Arvidsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thavendran","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"9685_CR1","first-page":"87","volume":"5","author":"S Ager","year":"2012","unstructured":"Ager S, Gould K (2012) Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infect Drug Resist 5:87\u2013102","journal-title":"Infect Drug Resist"},{"key":"9685_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10735-015-9634-3","volume":"46","author":"S Baijnath","year":"2015","unstructured":"Baijnath S, Naiker S, Shobo A, Moodley C, Adamson J, Ngcobo B, Bester LA, Singh S, Kruger HG, Naicker T (2015) Evidence for the presence of clofazimine and its distribution in the healthy mouse brain. J Mol Histol 46:439\u2013442","journal-title":"J Mol Histol"},{"key":"9685_CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/AAC.00515-06","volume":"51","author":"R Beer","year":"2007","unstructured":"Beer R, Engelhardt KW, Pfausler B, Broessner G, Helbok R, Lackner P, Brenneis C, Kaehler ST, Georgopoulos A, Schmutzhard E (2007) Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother 51:379\u2013382","journal-title":"Antimicrob Agents Chemother"},{"key":"9685_CR4","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/ejoc.201001720","volume":"2011","author":"S Chandrasekhar","year":"2011","unstructured":"Chandrasekhar S, Babu G, Mohapatra DK (2011) Practical Syntheses of (2S)-R207910 and (2R)-R207910. Eur J Org Chem 2011:2057\u20132061","journal-title":"Eur J Org Chem"},{"key":"9685_CR5","doi-asserted-by":"crossref","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","volume":"6","author":"MT Coleman","year":"2014","unstructured":"Coleman MT, Chen RY, Lee M, Lin PL, Dodd LE, Maiello P, Via LE, Kim Y, Marriner G, Dartois V (2014) PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis. Sci Transl Med 6:265ra167","journal-title":"Sci Transl Med"},{"key":"9685_CR6","first-page":"iv7","volume":"66","author":"MS Dryden","year":"2011","unstructured":"Dryden MS (2011) Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother 66:iv7\u2013iv15","journal-title":"J Antimicrob Chemother"},{"key":"9685_CR7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.45.6.1843-1846.2001","volume":"45","author":"T Gee","year":"2001","unstructured":"Gee T, Ellis R, Marshall G, Andrews J, Ashby J, Wise R (2001) Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 45:1843\u20131846","journal-title":"Antimicrob Agents Chemother"},{"key":"9685_CR8","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/INF.0b013e3181f20ed5","volume":"29","author":"A Krzysztofiak","year":"2010","unstructured":"Krzysztofiak A, Bozzola E, Lancella L, Quondamcarlo A, Gesualdo F, Ugazio AG (2010) Linezolid therapy of brain abscess. Pediatr Infect Dis J 29:1063\u20131064","journal-title":"Pediatr Infect Dis J"},{"key":"9685_CR9","doi-asserted-by":"crossref","first-page":"ii17","DOI":"10.1093\/jac\/dkg248","volume":"51","author":"AP MacGowan","year":"2003","unstructured":"MacGowan AP (2003) Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother 51:ii17\u2013ii25","journal-title":"J Antimicrob Chemother"},{"key":"9685_CR10","first-page":"148","volume":"3","author":"DJ Magee","year":"2014","unstructured":"Magee DJ (2014) Orthopedic physical assessment. Elsevier Health Sci 3:148\u2013152","journal-title":"Elsevier Health Sci"},{"key":"9685_CR11","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1128\/AAC.00276-12","volume":"56","author":"A Marra","year":"2012","unstructured":"Marra A, Lamb L, Medina I, George D, Gibson G, Hardink J, Rugg J, Van Deusen J, O\u2019Donnell JP (2012) Effect of linezolid on the 50\u00a0% lethal dose and 50\u00a0% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia. Antimicrob Agents Chemother 56:4671\u20134675","journal-title":"Antimicrob Agents Chemother"},{"key":"9685_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","volume":"138","author":"RC Moellering","year":"2003","unstructured":"Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 138:135\u2013142","journal-title":"Ann Intern Med"},{"key":"9685_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00498254.2015.1081307","volume":"46","author":"CF Munyeza","year":"2015","unstructured":"Munyeza CF, Shobo A, Baijnath S, Bratkowska D, Naiker S, Bester LA, Singh SD, Maguire GE, Kruger HG, Naicker T (2015) Rapid and widespread distribution of doxycycline in rat brain: a mass spectrometric imaging study. Xenobiotica 46:385\u2013392","journal-title":"Xenobiotica"},{"key":"9685_CR14","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","volume":"50","author":"P Myrianthefs","year":"2006","unstructured":"Myrianthefs P, Markantonis SL, Vlachos K, Anagnostaki M, Boutzouka E, Panidis D, Baltopoulos G (2006) Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 50:3971\u20133976","journal-title":"Antimicrob Agents Chemother"},{"key":"9685_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","volume":"50","author":"G Schecter","year":"2010","unstructured":"Schecter G, Scott C, True L, Raftery A, Flood J, Mase S (2010) Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 50:49\u201355","journal-title":"Clin Infect Dis"},{"key":"9685_CR16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/acsmedchemlett.5b00213","volume":"6","author":"B Seetharamsingh","year":"2015","unstructured":"Seetharamsingh B, Ramesh R, Dange SS, Khairnar PV, Singhal S, Upadhyay D, Veeraraghavan S, Viswanadha S, Vakkalanka S, Reddy DS (2015) Design, synthesis, and identification of silicon incorporated oxazolidinone antibiotics with improved brain exposure. ACS Med Chem Lett 6:1105\u20131110","journal-title":"ACS Med Chem Lett"},{"key":"9685_CR17","first-page":"375","volume":"33","author":"Z Shaikh","year":"2000","unstructured":"Shaikh Z, Peloquin CA, Ericsson CD (2000) Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 33:375\u2013379","journal-title":"Scand J Infect Dis"},{"key":"9685_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1862","author":"A Shobo","year":"2015","unstructured":"Shobo A, Baijnath S, Bratkowska D, Naiker S, Somboro AM, Bester LA, Singh SD, Naicker T, Kruger HG, Govender T (2015a) MALDI MSI and LC-MS\/MS: Towards preclinical determination of the neurotoxic potential of fluoroquinolones. Drug Test Anal. doi: 10.1002\/dta.1862","journal-title":"Drug Test Anal"},{"key":"9685_CR19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/adt.2015.634","volume":"13","author":"A Shobo","year":"2015","unstructured":"Shobo A, Bratkowska D, Baijnath S, Naiker S, Bester LA, Singh SD, Maguire GEM, Kruger HG, Govender T (2015b) Visualization of time-dependent distribution of rifampicin in rat brain using MALDI MSI and quantitative LCMS\/MS. Assay Drug Dev Technol 13:277\u2013284","journal-title":"Assay Drug Dev Technol"},{"key":"9685_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00498254.2015.1067935","volume":"46","author":"A Shobo","year":"2015","unstructured":"Shobo A, Bratkowska D, Baijnath S, Naiker S, Somboro AM, Bester LA, Singh SD, Naicker T, Kruger HG, Govender T (2015c) Tissue distribution of pretomanid in rat brain via mass spectrometry imaging. Xenobiotica 46:247\u2013252","journal-title":"Xenobiotica"},{"key":"9685_CR21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/00498250210158249","volume":"32","author":"J Slatter","year":"2002","unstructured":"Slatter J, Adams L, Bush E, Chiba K, Daley-Yates P, Feenstra K, Koike S, Ozawa N, Peng G, Sams J (2002) Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica 32:907\u2013924","journal-title":"Xenobiotica"},{"key":"9685_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/joc.2010.22.1.17","volume":"22","author":"A Tsona","year":"2010","unstructured":"Tsona A, Metallidis S, Foroglou N, Selviaridis P, Chrysanthidis T, Lazaraki G, Papaioannou M, Nikolaidis J, Nikolaidis P (2010) Linezolid penetration into cerebrospinal fluid and brain tissue. J Chemother 22:17\u201319","journal-title":"J Chemother"},{"key":"9685_CR24","first-page":"90","volume":"2","author":"SA Tukaram","year":"2007","unstructured":"Tukaram SA, Smith AA, Muthu AK, Chugh Y, Manavalan R (2007) Systemic safety evaluation of central nervous system function in the rat by oral administration of linezolid. Pharmacol 2: 90\u2013102","journal-title":"Pharmacol"},{"key":"9685_CR23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/AAC.46.3.936-937.2002","volume":"46","author":"P Villani","year":"2002","unstructured":"Villani P, Regazzi M, Marubbi F, Viale P, Pagani L, Cristini F, Cadeo B, Carosi G, Bergomi R (2002) Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 46:936\u2013937","journal-title":"Antimicrob Agents Chemother"},{"key":"9685_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkm506","volume":"61","author":"S Youssef","year":"2008","unstructured":"Youssef S, Hachem R, Chemaly R, Adachi J, Ying J, Rolston K, Raad I (2008) The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother 61:421\u2013424","journal-title":"J Antimicrob Chemother"},{"key":"9685_CR26","first-page":"603","volume":"7","author":"X Zhang","year":"2015","unstructured":"Zhang X, Falagas ME, Vardakas KZ, Wang R, Qin R, Wang J, Liu Y (2015) Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. J Thorac Dis 7:603\u2013615","journal-title":"J Thorac Dis"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-016-9685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10735-016-9685-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-016-9685-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:46:43Z","timestamp":1498322803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10735-016-9685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1007\/s10735-016-9685-0","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]}}}